Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
Phase 2 Trial Now Underway for GLPG1205
-
Phase 2 Trial Now Underway for GLPG1205
Galapagos has launched a Phase 2 trial testing the safety and effectiveness of investigational therapy GLPG1205 for idiopathic pulmonary fibrosis. Click here to find out more.
Are you interested in more news about this study?
Sorry, there were no replies found.
Log in to reply.